There is a great demand for topical analgesics. According to recent statistics, the global topical analgesics market targeting mild to moderate pain is worth $10.26 billion.
Many topical pain agents were originally developed as oral or injected drugs and later reformulated in a dosage more suited to topical administration (e.g., creams, gels, ointments). These include salicylates, nonsteroidal anti-inflammatory drugs (NSAIDs), capsaicinoids, corticosteroids and opioids. Physicians currently recommend these medicines to treat localized eczema, contact dermatitis, psoriasis, abrasions, muscle aches, etc.
Given their …